In the media 9 Jan 2025 Pourquoi les derniers cas de maladie du sommeil seront les plus difficiles à éliminer ? Nature
Scientific articles 10 Jan 2025 Congenital Chagas disease: A cohort study to assess molecular diagnostic methods at the Chagas disease national reference center of Argentina PLOS Neglected Tropical Diseases
In the media 9 Jan 2025 Why the last cases of sleeping sickness will be the hardest to eliminate Nature
In the media 6 Jan 2025 We asked global thinkers how to improve life on earth in 2025. Here are their wishes NPR
Scientific articles 20 Dec 2024 Challenges of sharing individual participant data for secondary research on neglected tropical diseases: the experience of Drugs for Neglected Diseases initiative and a call for action BMJ Open
News 19 Dec 2024 Message on the passing of Dr Yves Champey from DNDi Executive Director Dr Luis Pizarro
In the media 11 Dec 2024 «Pour convaincre le capital privé d’investir en faveur de la nature, il faut lui offrir des options de sortie» Agefi
In the media 9 Dec 2024 Interview de Laurent Fraisse sur les besoins pédiatriques liés aux maladies tropicales négligées RFI Priorité Santé
Press releases 31 Oct 2024 DNDi welcomes new G20 coalition focused on innovation, local and regional production, and equitable access to health tools
Press releases 17 Jul 2024 Clinical trial in Eastern Africa finds a shorter, safer, and more effective treatment for PKDL, a stigmatizing skin disease
Press releases 1 Jul 2024 WHO recommends first all-oral treatment for acute sleeping sickness found in Eastern and Southern Africa
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Press releases 9 May 2024 DNDi welcomes GHIT Fund’s renewed support to optimize novel compounds to treat Chagas disease
Press releases 23 Apr 2024 Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
Press releases 3 Apr 2024 DNDi signs memorandum of understanding with Kenya Medical Research Institute
Press releases 30 Jan 2024 DNDi receives USD 20 million to develop innovative treatments to further elimination goals for sleeping sickness and river blindness
Press releases 10 Jan 2024 Clinical trial confirms the tolerability of the drug fexinidazole in the treatment of Chagas disease
Press releases 15 Dec 2023 EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa
Press releases 8 Dec 2023 Nagasaki University, DNDi, and GHIT Fund sign agreement to collaborate on drug screening for Chagas disease
Press releases 5 Dec 2023 Cryptococcal meningitis: new report highlights slow uptake of guidelines shown to reduce deaths in Africa
Press releases 3 Dec 2023 Germany’s Federal Ministry for Economic Cooperation and Development (BMZ) through KfW grants funding to fast-track access to medicines for poverty-related and neglected diseases
Press releases 23 Nov 2023 World’s first clinical trial for devastating fungal disease mycetoma shows efficacy of new, promising treatment
Press releases 16 Oct 2023 DNDi signs memorandum of understanding with Spanish Agency for International Development Cooperation
